BRKR Bruker Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: BRKR

Price (delayed)

$77.32

Market cap

$11.35B

P/E Ratio

38.66

Dividend/share

$0.2

EPS

$2

Enterprise value

$11.95B

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions ...

Highlights
BRKR's equity is up by 19% QoQ and by 4% YoY
BRKR's EPS is up by 9% year-on-year and by 9% since the previous quarter
BRKR's price to earnings (P/E) is 17% higher than its last 4 quarters average of 33.0 but 4.8% lower than its 5-year quarterly average of 40.6
Bruker's debt has decreased by 9% YoY but it has increased by 9% from the previous quarter
The quick ratio has decreased by 28% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.bruker.com
Peers: PKI TMO WAT BIO

Key stats

What are the main financial stats of BRKR
Market
Shares outstanding
146.73M
Market cap
$11.35B
Enterprise value
$11.95B
Valuations
Price to earnings (P/E)
38.66
Price to book (P/B)
10.21
Price to sales (P/S)
4.54
EV/EBIT
28.94
EV/EBITDA
23.82
EV/Sales
4.72
Earnings
Revenue
$2.53B
EBIT
$413M
EBITDA
$501.8M
Free cash flow
$159.1M
Per share
EPS
$2
Free cash flow per share
$1.07
Book value per share
$7.57
Revenue per share
$17.03
TBVPS
$19.4
Balance sheet
Total assets
$3.61B
Total liabilities
$2.49B
Debt
$1.25B
Equity
$1.11B
Working capital
$1.2B
Liquidity
Debt to equity
1.13
Current ratio
2.31
Quick ratio
1.22
Net debt/EBITDA
1.21
Margins
EBITDA margin
19.8%
Gross margin
51.6%
Net margin
11.7%
Operating margin
17.1%
Efficiency
Return on assets
8.5%
Return on equity
29.4%
Return on invested capital
16.8%
Return on capital employed
15.3%
Return on sales
16.3%
Dividend
Dividend yield
0.26%
DPS
$0.2
Payout ratio
10%

BRKR stock price

How has the Bruker stock price performed over time
Intraday
1.44%
1 week
4.2%
1 month
12.19%
1 year
13.41%
YTD
13.12%
QTD
13.12%

Financial performance

How have Bruker's revenue and profit performed over time
Revenue
$2.53B
Gross profit
$1.31B
Operating income
$432.7M
Net income
$296.6M
Gross margin
51.6%
Net margin
11.7%
BRKR's gross profit is up by 8% year-on-year
The net income is up by 8% since the previous quarter and by 7% year-on-year
Bruker's net margin has increased by 6% from the previous quarter
BRKR's operating income is up by 4.7% year-on-year

Growth

What is Bruker's growth rate over time

Valuation

What is Bruker stock price valuation
P/E
38.66
P/B
10.21
P/S
4.54
EV/EBIT
28.94
EV/EBITDA
23.82
EV/Sales
4.72
BRKR's price to earnings (P/E) is 17% higher than its last 4 quarters average of 33.0 but 4.8% lower than its 5-year quarterly average of 40.6
BRKR's EPS is up by 9% year-on-year and by 9% since the previous quarter
The stock's price to book (P/B) is 25% more than its 5-year quarterly average of 8.2 and 11% more than its last 4 quarters average of 9.2
BRKR's equity is up by 19% QoQ and by 4% YoY
The stock's price to sales (P/S) is 26% more than its 5-year quarterly average of 3.6 and 23% more than its last 4 quarters average of 3.7
Bruker's revenue has increased by 4.7% YoY

Efficiency

How efficient is Bruker business performance
Bruker's return on invested capital has decreased by 15% YoY
Bruker's return on equity has increased by 9% YoY and by 7% QoQ
BRKR's return on assets is up by 8% since the previous quarter

Dividends

What is BRKR's dividend history
Dividend details
DPS
$0.2
Dividend yield
0.26%
Payout ratio
10%
Recent dividends

Financial health

How did Bruker financials performed over time
BRKR's total assets is 45% greater than its total liabilities
The quick ratio has decreased by 28% YoY
BRKR's current ratio is down by 12% year-on-year and by 2.1% since the previous quarter
Bruker's debt is 13% more than its equity
BRKR's equity is up by 19% QoQ and by 4% YoY
BRKR's debt to equity is down by 12% year-on-year and by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.